Evaluation of the Global Auditory Nerve Activity for Exploration of Hearing in Humans

Overview

To date, all the electrophysiological methods for auditory testing rely on the measure on synchronous evoked auditory nerve activity. This measure only takes into account the response of the first action potential in every auditory fibber, but provides no information about the neural response during a sustained activity. This can explain why in experimental models, a loss of more of 80% of auditory nerve fibbers cannot be detected by usual electrophysiological measurements. In this study we aim at investigating the global spontaneous and sound evoked auditory nerve activity by recording directly the electrical field by an electrode placed directly on the auditory nerve of subjects during a skull base surgical procedure. We expected to demonstrated differences in the electrical activity between subjects with or without hearing loss.

Full Title of Study: “Evaluation of the Global Auditory Nerve Activity as a New Method of Electrophysiological Exploration of Hearing in Humans – 2”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Basic Science
    • Masking: None (Open Label)
  • Study Primary Completion Date: June 26, 2021

Interventions

  • Procedure: Recording of auditory nerve activity
    • near field recording of auditory nerve activity with contact electrode

Arms, Groups and Cohorts

  • Experimental: Subjects with no hearing loss
    • Subjects referred for cerebellopontine angle surgery with no hearing loss with recording of auditory nerve activity by contact electrode
  • Experimental: Subjects with hearing loss
    • Subjects referred for cerebellopontine angle surgery with hearing loss with recording of auditory nerve activity by contact electrode

Clinical Trial Outcome Measures

Primary Measures

  • Amplitude of global evoked auditory nerve activity
    • Time Frame: 36 months
  • Spectrum of global evoked auditory nerve activity
    • Time Frame: 36 months

Secondary Measures

  • Mesure of peristimulus time responses of evoked auditory nerve activity
    • Time Frame: 36 months

Participating in This Clinical Trial

Inclusion Criteria

  • 18 – 80 years ( inclusive borders) – patient having to undergo surgery at the level of the ponto-cerebellar angle (microvascular decompression, vestibular neurotomy, tumor resection of the meningioma type or schwannoma) and – Unaffected by neuro-sensory hearing loss, defined by mean auditory thresholds of less than 20 dB in tone audiometry in bone conduction on the side of the ear to be operated (N = 15, Group 1) or – Showing mild to moderate hearing loss defined by average hearing loss (average of 500, 1000, 2000 and 4000 Hz thresholds) greater than 20 dB and less than 55 dB in air conduction threshold tone audiometry (N = 15 Group 2). – Voluntary subjects to participate in the study, – Subjects having signed written consent to participate in the study, – Easily accessible topics. Exclusion Criteria:

  • Subjects unable to understand the nature and goals of the study and / or having difficulty communicating with the investigator, – Subjects refusing to participate, subjects whose free and informed consent has not been sought, subjects for which a consent form has not been signed, – Subjects for whom there is a contraindication to general anesthesia, – Subjects with a central neurological pathology that can disrupt electrophysiological recordings – Not affiliated to a French social security scheme or not benefiting from such a scheme, – Majors protected by law, – Pregnant women, – deprived of liberty by judicial or administrative decision, – Infectious or inflammatory pathology of the middle ear.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Hospital, Montpellier
  • Collaborator
    • Institute for Neurosciences of Montpellier U1051
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Frédéric VENAIL, PU-PH, Principal Investigator, University Hospital, Montpellier

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.